Trials / Completed
CompletedNCT00808262
Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease
A Phase I/II, Open-label, Escalating Dose, "Optimal Two-stage", Study of TNFα-Kinoid (TNF- K) Immunization in Crohn's Disease Patients
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Neovacs · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the safety and the immune response induced by active immunization through a TNFa kinoid in patients with Crohn's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | TNFa Kinoid | TNFa kinoid at days 0, 7, 28 |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2008-12-15
- Last updated
- 2011-06-08
Locations
6 sites across 2 countries: South Africa, Switzerland
Source: ClinicalTrials.gov record NCT00808262. Inclusion in this directory is not an endorsement.